Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Effect of Branched Chain Amino Acids Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in Patients With Chronic Liver Disease - A Randomized Controlled Trial.
Authors not listed
Institute of Liver and Biliary Sciences, India · 2020
Abstract
Loss of muscle mass (sarcopenia) is a major complication in a patient with cirrhosis, impacting the disease outcome, quality of life and survival. Cirrhotics lose muscle mass (MM) while waiting for liver transplant (LT) and even after LT, impacting the outcome of LT. Moreover, LT is elusive for majority of patients in India. The pathophysiology of muscle loss is complicated, multifactorial, interlinked and primarily nutrition driven, which gives clues for targeted therapeutic modalities other than feeding alone. Experimental studies have instilled faith in BCAA in successfully counteracting the pathogenesis of muscle loss. But there is lack of convincing data from clinical studies with direct evidence on muscle growth per se.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Anonymous. (2020). Effect of Branched Chain Amino Acids Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in Patients With Chronic Liver Disease - A Randomized Controlled Trial. <em>Institute of Liver and Biliary Sciences, India</em>. https://clinicaltrials.gov/study/NCT04246918
Vancouver
Anonymous. Effect of Branched Chain Amino Acids Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in Patients With Chronic Liver Disease - A Randomized Controlled Trial. Institute of Liver and Biliary Sciences, India. 2020.
BibTeX
@misc{anon2020Effect,
title = {Effect of Branched Chain Amino Acids Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in Patients With Chronic Liver Disease - A Randomized Controlled Trial.},
author = {Anonymous},
journal = {Institute of Liver and Biliary Sciences, India},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
London North West Healthcare NHS Trust 2022
Open access · US-GOV
Use of Perioperative Testosterone Replacement Therapy (TRT) in Sarcopenic Male Colorectal Cancer Patients - A Single Arm Open Label Feasibility Study
Aging Clinical and Experimental Research 2017
Citation only
Measurement of muscle mass in sarcopenia: from imaging to biochemical markers
Aging and Disease 2026
Open access · CC-BY
Mitochondrial Inflammation and Muscle Aging: Targeting the Inflammatory Microenvironment in Sarcopenic Muscle
Institute of Liver and Biliary Sciences, India 2023
Open access · US-GOV
Effect of Exercise Based Regimen on Frailty in Children With Liver Disease -A Randomized Controlled Trial
Hospices Civils de Lyon 2022
Open access · US-GOV
Role of FGF19 in Sarcopenia Associated with Chronic Kidney Disease
The Affiliated Hospital of Qingdao University 2021
Open access · US-GOV